Huntington’s Disease
FDA Approves Ingrezza (valbenazine) Capsules to Treat Chorea in Huntington’s Disease
Anika Sharma
Neurocrine Biosciences has achieved a significant milestone with the announcement of US Food and Drug Administration (FDA) approval for Ingrezza ...
